clenbuterol has been researched along with Vasospasm, Intracranial in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the possible therapeutic effects of clenbuterol on cerebral vasospasm after subarachnoid hemorrhage (SAH) in rats." | 7.77 | The effects of clenbuterol on cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage. ( Acar, F; Benek, B; Cirak, B; Coskun, E; Ozcakar, L; Suzer, T; Tahta, K; Yalcin, N, 2011) |
| "To investigate the possible therapeutic effects of clenbuterol on cerebral vasospasm after subarachnoid hemorrhage (SAH) in rats." | 3.77 | The effects of clenbuterol on cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage. ( Acar, F; Benek, B; Cirak, B; Coskun, E; Ozcakar, L; Suzer, T; Tahta, K; Yalcin, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benek, B | 1 |
| Acar, F | 1 |
| Cirak, B | 1 |
| Coskun, E | 1 |
| Ozcakar, L | 1 |
| Yalcin, N | 1 |
| Suzer, T | 1 |
| Tahta, K | 1 |
1 other study available for clenbuterol and Vasospasm, Intracranial
| Article | Year |
|---|---|
The effects of clenbuterol on cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.
Topics: Adrenergic beta-Agonists; Animals; Basilar Artery; Cerebrovascular Circulation; Clenbuterol; Disease | 2011 |